News Conference News ESC 2025 Home-Based Intervention Drops Blood Pressure in Rural South Africa Todd Neale September 04, 2025
News Conference News ESC 2025 BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension Todd Neale August 31, 2025
News Conference News ESC 2022 COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19 Todd Neale September 01, 2022
News Conference News ESC 2022 Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms Yael L. Maxwell August 31, 2022
News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 ‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET Caitlin E. Cox August 31, 2021
Presentation ESC 2021 Influenza Vaccination after Myocardial Infarction - a randomized, double-blind, placebo-controlled, multicenter trial Presenter: Ole Fröbert August 31, 2021
News Conference News ESC 2021 IAMI: Influenza Vaccine Beneficial for Post-MI Patients Michael O'Riordan August 30, 2021
News Conference News ESC 2020 ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA Michael O'Riordan September 01, 2020
News Conference News ESC 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016